Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 15
2019 21
2020 27
2021 20
2022 19
2023 11
2024 10
2025 10
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Results by year

Filters applied: . Clear all
Page 1
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE; SANAD II collaborators. Marson A, et al. Lancet. 2021 Apr 10;397(10282):1363-1374. doi: 10.1016/S0140-6736(21)00247-6. Lancet. 2021. PMID: 33838757 Free PMC article. Clinical Trial.
Zonisamide add-on therapy for focal epilepsy.
Brigo F, Lattanzi S, Igwe SC, Behzadifar M, Bragazzi NL. Brigo F, et al. Cochrane Database Syst Rev. 2020 Jul 24;7(7):CD001416. doi: 10.1002/14651858.CD001416.pub5. Cochrane Database Syst Rev. 2020. PMID: 32715463 Free PMC article.
Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
Marson AG, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton CO, Hughes DA, Williamson PR, Baker G, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE. Marson AG, et al. Health Technol Assess. 2021 Dec;25(75):1-134. doi: 10.3310/hta25750. Health Technol Assess. 2021. PMID: 34931602 Free article. Clinical Trial.
[Zonisamide treatment in myoclonus-dystonia].
Salamon A, Zádori D, Horváth E, Vécsei L, Klivényi P. Salamon A, et al. Orv Hetil. 2019 Aug;160(34):1353-1357. doi: 10.1556/650.2019.31472. Orv Hetil. 2019. PMID: 31423828 Hungarian.
Zonisamide serum concentrations during pregnancy.
Reimers A, Helde G, Becser Andersen N, Aurlien D, Surlien Navjord E, Haggag K, Christensen J, Lillestølen KM, Nakken KO, Brodtkorb E. Reimers A, et al. Epilepsy Res. 2018 Aug;144:25-29. doi: 10.1016/j.eplepsyres.2018.05.002. Epub 2018 May 4. Epilepsy Res. 2018. PMID: 29751353
124 results